0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Povidone K30 Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-20C17549
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Povidone K30 Market Research Report 2024
BUY CHAPTERS

Global Povidone K30 Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-20C17549
Report
October 2025
Pages:153
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Povidone K30 Market

The global Povidone K30 market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Povidone K-30, also known as polyvinylpyrrolidone or polyvidone, is a polymer. Povidone (polyvinylpyrrolidone, PVP) is used in the pharmaceutical industry as a synthetic polymer vehicle for dispersing and suspending drugs. Povidone K30 is used as thickeners, dispersing agents, detoxicant, complexing agent, lubricants and binders in pharmaceutical industry.
From a downstream perspective, Pharmaceuticals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Povidone K30 leading manufacturers including BASF, Ashland, Boai NKY Medical Holdings, DKS, JRS Pharma, JH Nanhang Life Sciences, Cnsg Anhui Hongsifang, Sichuan Tianhua, Huangshan Bonsun Pharmaceutical, Jiaozuo Zhongwei Special Products Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with BASF leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Povidone K30 market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Povidone K30 Market Report

Report Metric Details
Report Name Povidone K30 Market
Segment by Type
  • Povidone K30 Powder
  • Povidone K30 Liquid
Segment by Application
  • Pharmaceuticals
  • Daily Chemicals
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company BASF, Ashland, Boai NKY Medical Holdings, DKS, JRS Pharma, JH Nanhang Life Sciences, Cnsg Anhui Hongsifang, Sichuan Tianhua, Huangshan Bonsun Pharmaceutical, Jiaozuo Zhongwei Special Products Pharmaceutical, Hangzhou Motto Science&Technology, Shanghai Yuking Water Soluble Material Technology, Anhui Sunhere Pharmaceutical Excipients
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Povidone K30 study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
  • Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
  • Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Povidone K30 Market report?

Ans: The main players in the Povidone K30 Market are BASF, Ashland, Boai NKY Medical Holdings, DKS, JRS Pharma, JH Nanhang Life Sciences, Cnsg Anhui Hongsifang, Sichuan Tianhua, Huangshan Bonsun Pharmaceutical, Jiaozuo Zhongwei Special Products Pharmaceutical, Hangzhou Motto Science&Technology, Shanghai Yuking Water Soluble Material Technology, Anhui Sunhere Pharmaceutical Excipients

What are the Application segmentation covered in the Povidone K30 Market report?

Ans: The Applications covered in the Povidone K30 Market report are Pharmaceuticals, Daily Chemicals, Others

What are the Type segmentation covered in the Povidone K30 Market report?

Ans: The Types covered in the Povidone K30 Market report are Povidone K30 Powder, Povidone K30 Liquid

Recommended Reports

Medical Polymers

Pharmaceutical Ingredients

Diagnostics & Devices

1 Study Coverage
1.1 Introduction to Povidone K30: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Povidone K30 Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Povidone K30 Powder
1.2.3 Povidone K30 Liquid
1.3 Market Segmentation by Application
1.3.1 Global Povidone K30 Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceuticals
1.3.3 Daily Chemicals
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Povidone K30 Revenue Estimates and Forecasts 2020-2031
2.2 Global Povidone K30 Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Povidone K30 Sales Estimates and Forecasts 2020-2031
2.4 Global Povidone K30 Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Povidone K30 Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Povidone K30 Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Povidone K30 Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Povidone K30 Powder Market Size by Manufacturers
4.5.2 Povidone K30 Liquid Market Size by Manufacturers
4.6 Global Povidone K30 Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Povidone K30 Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Povidone K30 Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Povidone K30 Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Povidone K30 Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Povidone K30 Sales and Revenue by Type (2020-2031)
7.4 North America Povidone K30 Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Povidone K30 Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Povidone K30 Sales and Revenue by Type (2020-2031)
8.4 Europe Povidone K30 Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Povidone K30 Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Povidone K30 Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Povidone K30 Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Povidone K30 Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Povidone K30 Sales and Revenue by Type (2020-2031)
10.4 Central and South America Povidone K30 Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Povidone K30 Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Povidone K30 Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Povidone K30 Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Povidone K30 Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 BASF
12.1.1 BASF Corporation Information
12.1.2 BASF Business Overview
12.1.3 BASF Povidone K30 Product Models, Descriptions and Specifications
12.1.4 BASF Povidone K30 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 BASF Povidone K30 Sales by Product in 2024
12.1.6 BASF Povidone K30 Sales by Application in 2024
12.1.7 BASF Povidone K30 Sales by Geographic Area in 2024
12.1.8 BASF Povidone K30 SWOT Analysis
12.1.9 BASF Recent Developments
12.2 Ashland
12.2.1 Ashland Corporation Information
12.2.2 Ashland Business Overview
12.2.3 Ashland Povidone K30 Product Models, Descriptions and Specifications
12.2.4 Ashland Povidone K30 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Ashland Povidone K30 Sales by Product in 2024
12.2.6 Ashland Povidone K30 Sales by Application in 2024
12.2.7 Ashland Povidone K30 Sales by Geographic Area in 2024
12.2.8 Ashland Povidone K30 SWOT Analysis
12.2.9 Ashland Recent Developments
12.3 Boai NKY Medical Holdings
12.3.1 Boai NKY Medical Holdings Corporation Information
12.3.2 Boai NKY Medical Holdings Business Overview
12.3.3 Boai NKY Medical Holdings Povidone K30 Product Models, Descriptions and Specifications
12.3.4 Boai NKY Medical Holdings Povidone K30 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Boai NKY Medical Holdings Povidone K30 Sales by Product in 2024
12.3.6 Boai NKY Medical Holdings Povidone K30 Sales by Application in 2024
12.3.7 Boai NKY Medical Holdings Povidone K30 Sales by Geographic Area in 2024
12.3.8 Boai NKY Medical Holdings Povidone K30 SWOT Analysis
12.3.9 Boai NKY Medical Holdings Recent Developments
12.4 DKS
12.4.1 DKS Corporation Information
12.4.2 DKS Business Overview
12.4.3 DKS Povidone K30 Product Models, Descriptions and Specifications
12.4.4 DKS Povidone K30 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 DKS Povidone K30 Sales by Product in 2024
12.4.6 DKS Povidone K30 Sales by Application in 2024
12.4.7 DKS Povidone K30 Sales by Geographic Area in 2024
12.4.8 DKS Povidone K30 SWOT Analysis
12.4.9 DKS Recent Developments
12.5 JRS Pharma
12.5.1 JRS Pharma Corporation Information
12.5.2 JRS Pharma Business Overview
12.5.3 JRS Pharma Povidone K30 Product Models, Descriptions and Specifications
12.5.4 JRS Pharma Povidone K30 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 JRS Pharma Povidone K30 Sales by Product in 2024
12.5.6 JRS Pharma Povidone K30 Sales by Application in 2024
12.5.7 JRS Pharma Povidone K30 Sales by Geographic Area in 2024
12.5.8 JRS Pharma Povidone K30 SWOT Analysis
12.5.9 JRS Pharma Recent Developments
12.6 JH Nanhang Life Sciences
12.6.1 JH Nanhang Life Sciences Corporation Information
12.6.2 JH Nanhang Life Sciences Business Overview
12.6.3 JH Nanhang Life Sciences Povidone K30 Product Models, Descriptions and Specifications
12.6.4 JH Nanhang Life Sciences Povidone K30 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 JH Nanhang Life Sciences Recent Developments
12.7 Cnsg Anhui Hongsifang
12.7.1 Cnsg Anhui Hongsifang Corporation Information
12.7.2 Cnsg Anhui Hongsifang Business Overview
12.7.3 Cnsg Anhui Hongsifang Povidone K30 Product Models, Descriptions and Specifications
12.7.4 Cnsg Anhui Hongsifang Povidone K30 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Cnsg Anhui Hongsifang Recent Developments
12.8 Sichuan Tianhua
12.8.1 Sichuan Tianhua Corporation Information
12.8.2 Sichuan Tianhua Business Overview
12.8.3 Sichuan Tianhua Povidone K30 Product Models, Descriptions and Specifications
12.8.4 Sichuan Tianhua Povidone K30 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Sichuan Tianhua Recent Developments
12.9 Huangshan Bonsun Pharmaceutical
12.9.1 Huangshan Bonsun Pharmaceutical Corporation Information
12.9.2 Huangshan Bonsun Pharmaceutical Business Overview
12.9.3 Huangshan Bonsun Pharmaceutical Povidone K30 Product Models, Descriptions and Specifications
12.9.4 Huangshan Bonsun Pharmaceutical Povidone K30 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Huangshan Bonsun Pharmaceutical Recent Developments
12.10 Jiaozuo Zhongwei Special Products Pharmaceutical
12.10.1 Jiaozuo Zhongwei Special Products Pharmaceutical Corporation Information
12.10.2 Jiaozuo Zhongwei Special Products Pharmaceutical Business Overview
12.10.3 Jiaozuo Zhongwei Special Products Pharmaceutical Povidone K30 Product Models, Descriptions and Specifications
12.10.4 Jiaozuo Zhongwei Special Products Pharmaceutical Povidone K30 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Jiaozuo Zhongwei Special Products Pharmaceutical Recent Developments
12.11 Hangzhou Motto Science&Technology
12.11.1 Hangzhou Motto Science&Technology Corporation Information
12.11.2 Hangzhou Motto Science&Technology Business Overview
12.11.3 Hangzhou Motto Science&Technology Povidone K30 Product Models, Descriptions and Specifications
12.11.4 Hangzhou Motto Science&Technology Povidone K30 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Hangzhou Motto Science&Technology Recent Developments
12.12 Shanghai Yuking Water Soluble Material Technology
12.12.1 Shanghai Yuking Water Soluble Material Technology Corporation Information
12.12.2 Shanghai Yuking Water Soluble Material Technology Business Overview
12.12.3 Shanghai Yuking Water Soluble Material Technology Povidone K30 Product Models, Descriptions and Specifications
12.12.4 Shanghai Yuking Water Soluble Material Technology Povidone K30 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Shanghai Yuking Water Soluble Material Technology Recent Developments
12.13 Anhui Sunhere Pharmaceutical Excipients
12.13.1 Anhui Sunhere Pharmaceutical Excipients Corporation Information
12.13.2 Anhui Sunhere Pharmaceutical Excipients Business Overview
12.13.3 Anhui Sunhere Pharmaceutical Excipients Povidone K30 Product Models, Descriptions and Specifications
12.13.4 Anhui Sunhere Pharmaceutical Excipients Povidone K30 Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 Anhui Sunhere Pharmaceutical Excipients Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Povidone K30 Industry Chain
13.2 Povidone K30 Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Povidone K30 Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Povidone K30 Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Povidone K30 Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Povidone K30 Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
List of Tables
 Table 1. Global Povidone K30 Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Povidone K30 Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Povidone K30 Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Povidone K30 Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Povidone K30 Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Povidone K30 Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Povidone K30 Sales by Region (2020-2025) & (Tons)
 Table 8. Global Povidone K30 Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Povidone K30 Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 11. Global Povidone K30 Production by Region (2020-2025) & (Tons)
 Table 12. Global Povidone K30 Production by Region (2026-2031) & (Tons)
 Table 13. Global Povidone K30 Sales by Manufacturers (2020-2025) & (Tons)
 Table 14. Global Povidone K30 Sales Share by Manufacturers (2020-2025)
 Table 15. Global Povidone K30 Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 16. Global Povidone K30 Revenue Market Share by Manufacturers (2020-2025)
 Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 18. Global Povidone K30 by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Povidone K30 as of 2024)
 Table 19. Global Povidone K30 Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 20. Global Povidone K30 Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Kg)
 Table 21. Key Manufacturers Povidone K30 Manufacturing Base and Headquarters
 Table 22. Global Povidone K30 Market Concentration Ratio (CR5 and HHI)
 Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 25. Global Povidone K30 Sales by Type (2020-2025) & (Tons)
 Table 26. Global Povidone K30 Sales by Type (2026-2031) & (Tons)
 Table 27. Global Povidone K30 Revenue by Type (2020-2025) & (US$ Million)
 Table 28. Global Povidone K30 Revenue by Type (2026-2031) & (US$ Million)
 Table 29. Global Povidone K30 ASP by Type (2020-2031) & (US$/Kg)
 Table 30. Technical Specifications by Key Product Type
 Table 31. Global Povidone K30 Sales by Application (2020-2025) & (Tons)
 Table 32. Global Povidone K30 Sales by Application (2026-2031) & (Tons)
 Table 33. Povidone K30 High-Growth Sectors Demand CAGR (2024-2031)
 Table 34. Global Povidone K30 Revenue by Application (2020-2025) & (US$ Million)
 Table 35. Global Povidone K30 Revenue by Application (2026-2031) & (US$ Million)
 Table 36. Global Povidone K30 ASP by Application (2020-2031) & (US$/Kg)
 Table 37. Top Customers by Region
 Table 38. Top Customers by Application
 Table 39. North America Povidone K30 Growth Accelerators and Market Barriers
 Table 40. North America Povidone K30 Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 41. North America Povidone K30 Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Europe Povidone K30 Growth Accelerators and Market Barriers
 Table 43. Europe Povidone K30 Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 44. Europe Povidone K30 Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 45. Asia-Pacific Povidone K30 Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Asia-Pacific Povidone K30 Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 47. Asia-Pacific Povidone K30 Growth Accelerators and Market Barriers
 Table 48. Southeast Asia Povidone K30 Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 49. Central and South America Povidone K30 Investment Opportunities and Key Challenges
 Table 50. Central and South America Povidone K30 Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 51. Middle East and Africa Povidone K30 Investment Opportunities and Key Challenges
 Table 52. Middle East and Africa Povidone K30 Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 53. BASF Corporation Information
 Table 54. BASF Description and Major Businesses
 Table 55. BASF Product Models, Descriptions and Specifications
 Table 56. BASF Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 57. BASF Sales Value Proportion by Product in 2024
 Table 58. BASF Sales Value Proportion by Application in 2024
 Table 59. BASF Sales Value Proportion by Geographic Area in 2024
 Table 60. BASF Povidone K30 SWOT Analysis
 Table 61. BASF Recent Developments
 Table 62. Ashland Corporation Information
 Table 63. Ashland Description and Major Businesses
 Table 64. Ashland Product Models, Descriptions and Specifications
 Table 65. Ashland Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 66. Ashland Sales Value Proportion by Product in 2024
 Table 67. Ashland Sales Value Proportion by Application in 2024
 Table 68. Ashland Sales Value Proportion by Geographic Area in 2024
 Table 69. Ashland Povidone K30 SWOT Analysis
 Table 70. Ashland Recent Developments
 Table 71. Boai NKY Medical Holdings Corporation Information
 Table 72. Boai NKY Medical Holdings Description and Major Businesses
 Table 73. Boai NKY Medical Holdings Product Models, Descriptions and Specifications
 Table 74. Boai NKY Medical Holdings Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 75. Boai NKY Medical Holdings Sales Value Proportion by Product in 2024
 Table 76. Boai NKY Medical Holdings Sales Value Proportion by Application in 2024
 Table 77. Boai NKY Medical Holdings Sales Value Proportion by Geographic Area in 2024
 Table 78. Boai NKY Medical Holdings Povidone K30 SWOT Analysis
 Table 79. Boai NKY Medical Holdings Recent Developments
 Table 80. DKS Corporation Information
 Table 81. DKS Description and Major Businesses
 Table 82. DKS Product Models, Descriptions and Specifications
 Table 83. DKS Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 84. DKS Sales Value Proportion by Product in 2024
 Table 85. DKS Sales Value Proportion by Application in 2024
 Table 86. DKS Sales Value Proportion by Geographic Area in 2024
 Table 87. DKS Povidone K30 SWOT Analysis
 Table 88. DKS Recent Developments
 Table 89. JRS Pharma Corporation Information
 Table 90. JRS Pharma Description and Major Businesses
 Table 91. JRS Pharma Product Models, Descriptions and Specifications
 Table 92. JRS Pharma Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. JRS Pharma Sales Value Proportion by Product in 2024
 Table 94. JRS Pharma Sales Value Proportion by Application in 2024
 Table 95. JRS Pharma Sales Value Proportion by Geographic Area in 2024
 Table 96. JRS Pharma Povidone K30 SWOT Analysis
 Table 97. JRS Pharma Recent Developments
 Table 98. JH Nanhang Life Sciences Corporation Information
 Table 99. JH Nanhang Life Sciences Description and Major Businesses
 Table 100. JH Nanhang Life Sciences Product Models, Descriptions and Specifications
 Table 101. JH Nanhang Life Sciences Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 102. JH Nanhang Life Sciences Recent Developments
 Table 103. Cnsg Anhui Hongsifang Corporation Information
 Table 104. Cnsg Anhui Hongsifang Description and Major Businesses
 Table 105. Cnsg Anhui Hongsifang Product Models, Descriptions and Specifications
 Table 106. Cnsg Anhui Hongsifang Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 107. Cnsg Anhui Hongsifang Recent Developments
 Table 108. Sichuan Tianhua Corporation Information
 Table 109. Sichuan Tianhua Description and Major Businesses
 Table 110. Sichuan Tianhua Product Models, Descriptions and Specifications
 Table 111. Sichuan Tianhua Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 112. Sichuan Tianhua Recent Developments
 Table 113. Huangshan Bonsun Pharmaceutical Corporation Information
 Table 114. Huangshan Bonsun Pharmaceutical Description and Major Businesses
 Table 115. Huangshan Bonsun Pharmaceutical Product Models, Descriptions and Specifications
 Table 116. Huangshan Bonsun Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 117. Huangshan Bonsun Pharmaceutical Recent Developments
 Table 118. Jiaozuo Zhongwei Special Products Pharmaceutical Corporation Information
 Table 119. Jiaozuo Zhongwei Special Products Pharmaceutical Description and Major Businesses
 Table 120. Jiaozuo Zhongwei Special Products Pharmaceutical Product Models, Descriptions and Specifications
 Table 121. Jiaozuo Zhongwei Special Products Pharmaceutical Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 122. Jiaozuo Zhongwei Special Products Pharmaceutical Recent Developments
 Table 123. Hangzhou Motto Science&Technology Corporation Information
 Table 124. Hangzhou Motto Science&Technology Description and Major Businesses
 Table 125. Hangzhou Motto Science&Technology Product Models, Descriptions and Specifications
 Table 126. Hangzhou Motto Science&Technology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 127. Hangzhou Motto Science&Technology Recent Developments
 Table 128. Shanghai Yuking Water Soluble Material Technology Corporation Information
 Table 129. Shanghai Yuking Water Soluble Material Technology Description and Major Businesses
 Table 130. Shanghai Yuking Water Soluble Material Technology Product Models, Descriptions and Specifications
 Table 131. Shanghai Yuking Water Soluble Material Technology Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 132. Shanghai Yuking Water Soluble Material Technology Recent Developments
 Table 133. Anhui Sunhere Pharmaceutical Excipients Corporation Information
 Table 134. Anhui Sunhere Pharmaceutical Excipients Description and Major Businesses
 Table 135. Anhui Sunhere Pharmaceutical Excipients Product Models, Descriptions and Specifications
 Table 136. Anhui Sunhere Pharmaceutical Excipients Capacity, Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 137. Anhui Sunhere Pharmaceutical Excipients Recent Developments
 Table 138. Key Raw Materials Distribution
 Table 139. Raw Materials Key Suppliers
 Table 140. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 141. Milestones in Production Technology Evolution
 Table 142. Distributors List
 Table 143. Market Trends and Market Evolution
 Table 144. Market Drivers and Opportunities
 Table 145. Market Challenges, Risks, and Restraints
 Table 146. Research Programs/Design for This Report
 Table 147. Key Data Information from Secondary Sources
 Table 148. Key Data Information from Primary Sources


List of Figures
 Figure 1. Povidone K30 Product Picture
 Figure 2. Global Povidone K30 Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Povidone K30 Powder Product Picture
 Figure 4. Povidone K30 Liquid Product Picture
 Figure 5. Global Povidone K30 Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Pharmaceuticals
 Figure 7. Daily Chemicals
 Figure 8. Others
 Figure 9. Povidone K30 Report Years Considered
 Figure 10. Global Povidone K30 Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Povidone K30 Revenue (2020-2031) & (US$ Million)
 Figure 12. Global Povidone K30 Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global Povidone K30 Revenue Market Share by Region (2020-2031)
 Figure 14. Global Povidone K30 Sales (2020-2031) & (Tons)
 Figure 15. Global Povidone K30 Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 16. Global Povidone K30 Sales Market Share by Region (2020-2031)
 Figure 17. Global Povidone K30 Capacity, Production and Utilization (2020-2031) & (Tons)
 Figure 18. Global Povidone K30 Production Trend by Region (2020-2031) (Tons)
 Figure 19. Global Povidone K30 Production Market Share by Region (2020-2031)
 Figure 20. Production Capacity Enablers & Constraints
 Figure 21. Povidone K30 Production Growth Rate in North America (2020-2031) & (Tons)
 Figure 22. Povidone K30 Production Growth Rate in Europe (2020-2031) & (Tons)
 Figure 23. Povidone K30 Production Growth Rate in China (2020-2031) & (Tons)
 Figure 24. Povidone K30 Production Growth Rate in Japan (2020-2031) & (Tons)
 Figure 25. Top 5 and Top 10 Manufacturers Povidone K30 Sales Volume Market Share in 2024
 Figure 26. Global Povidone K30 Revenue Market Share Ranking (2024)
 Figure 27. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 28. Povidone K30 Powder Revenue Market Share by Manufacturer in 2024
 Figure 29. Povidone K30 Liquid Revenue Market Share by Manufacturer in 2024
 Figure 30. Type Eight Revenue Market Share by Manufacturer in 2024
 Figure 31. Type Nine Revenue Market Share by Manufacturer in 2024
 Figure 32. Global Povidone K30 Sales Market Share by Type (2020-2031)
 Figure 33. Global Povidone K30 Revenue Market Share by Type (2020-2031)
 Figure 34. Global Povidone K30 Sales Market Share by Application (2020-2031)
 Figure 35. Global Povidone K30 Revenue Market Share by Application (2020-2031)
 Figure 36. North America Povidone K30 Sales YoY (2020-2031) & (Tons)
 Figure 37. North America Povidone K30 Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. North America Top 5 Manufacturers Povidone K30 Sales Revenue (US$ Million) in 2024
 Figure 39. North America Povidone K30 Sales Volume (Tons) by Type (2020- 2031)
 Figure 40. North America Povidone K30 Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 41. North America Povidone K30 Sales Volume (Tons) by Application (2020-2031)
 Figure 42. North America Povidone K30 Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. US Povidone K30 Revenue (2020-2031) & (US$ Million)
 Figure 44. Canada Povidone K30 Revenue (2020-2031) & (US$ Million)
 Figure 45. Mexico Povidone K30 Revenue (2020-2031) & (US$ Million)
 Figure 46. Europe Povidone K30 Sales YoY (2020-2031) & (Tons)
 Figure 47. Europe Povidone K30 Revenue YoY (2020-2031) & (US$ Million)
 Figure 48. Europe Top 5 Manufacturers Povidone K30 Sales Revenue (US$ Million) in 2024
 Figure 49. Europe Povidone K30 Sales Volume (Tons) by Type (2020-2031)
 Figure 50. Europe Povidone K30 Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 51. Europe Povidone K30 Sales Volume (Tons) by Application (2020-2031)
 Figure 52. Europe Povidone K30 Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Germany Povidone K30 Revenue (2020-2031) & (US$ Million)
 Figure 54. France Povidone K30 Revenue (2020-2031) & (US$ Million)
 Figure 55. U.K. Povidone K30 Revenue (2020-2031) & (US$ Million)
 Figure 56. Italy Povidone K30 Revenue (2020-2031) & (US$ Million)
 Figure 57. Russia Povidone K30 Revenue (2020-2031) & (US$ Million)
 Figure 58. Asia-Pacific Povidone K30 Sales YoY (2020-2031) & (Tons)
 Figure 59. Asia-Pacific Povidone K30 Revenue YoY (2020-2031) & (US$ Million)
 Figure 60. Asia-Pacific Top 8 Manufacturers Povidone K30 Sales Revenue (US$ Million) in 2024
 Figure 61. Asia-Pacific Povidone K30 Sales Volume (Tons) by Type (2020- 2031)
 Figure 62. Asia-Pacific Povidone K30 Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 63. Asia-Pacific Povidone K30 Sales Volume (Tons) by Application (2020-2031)
 Figure 64. Asia-Pacific Povidone K30 Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 65. Indonesia Povidone K30 Revenue (2020-2031) & (US$ Million)
 Figure 66. Japan Povidone K30 Revenue (2020-2031) & (US$ Million)
 Figure 67. South Korea Povidone K30 Revenue (2020-2031) & (US$ Million)
 Figure 68. China Taiwan Povidone K30 Revenue (2020-2031) & (US$ Million)
 Figure 69. India Povidone K30 Revenue (2020-2031) & (US$ Million)
 Figure 70. Central and South America Povidone K30 Sales YoY (2020-2031) & (Tons)
 Figure 71. Central and South America Povidone K30 Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Central and South America Top 5 Manufacturers Povidone K30 Sales Revenue (US$ Million) in 2024
 Figure 73. Central and South America Povidone K30 Sales Volume (Tons) by Type (2021-2031)
 Figure 74. Central and South America Povidone K30 Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Central and South America Povidone K30 Sales Volume (Tons) by Application (2020-2031)
 Figure 76. Central and South America Povidone K30 Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. Brazil Povidone K30 Revenue (2020-2025) & (US$ Million)
 Figure 78. Argentina Povidone K30 Revenue (2020-2025) & (US$ Million)
 Figure 79. Middle East, and Africa Povidone K30 Sales YoY (2020-2031) & (Tons)
 Figure 80. Middle East and Africa Povidone K30 Revenue YoY (2020-2031) & (US$ Million)
 Figure 81. Middle East and Africa Top 5 Manufacturers Povidone K30 Sales Revenue (US$ Million) in 2024
 Figure 82. Middle East and Africa Povidone K30 Sales Volume (Tons) by Type (2021-2031)
 Figure 83. South America Povidone K30 Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 84. Middle East and Africa Povidone K30 Sales Volume (Tons) by Application (2020-2031)
 Figure 85. Middle East and Africa Povidone K30 Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 86. GCC Countries Povidone K30 Revenue (2020-2025) & (US$ Million)
 Figure 87. Turkey Povidone K30 Revenue (2020-2025) & (US$ Million)
 Figure 88. Egypt Povidone K30 Revenue (2020-2025) & (US$ Million)
 Figure 89. South Africa Povidone K30 Revenue (2020-2025) & (US$ Million)
 Figure 90. Povidone K30 Industry Chain Mapping
 Figure 91. Regional Povidone K30 Manufacturing Base Distribution (%)
 Figure 92. Povidone K30 Production Process
 Figure 93. Regional Povidone K30 Production Cost Structure
 Figure 94. Channels of Distribution (Direct Vs Distribution)
 Figure 95. Bottom-up and Top-down Approaches for This Report
 Figure 96. Data Triangulation
 Figure 97. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India

SIMILAR REPORTS

RELATED REPORTS

Global Resorcinol Formaldehyde Adhesive Resin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19T20220
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Low-Sludge Phosphating Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33H20007
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Linear Alpha-Olefin Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5Y6896
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Nodulizer Cored Wire Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10G20315
Wed Dec 03 00:00:00 UTC 2025

Add to Cart